首页 > 市场调查报告书 > 医疗设备

血液学市场规模、份额和成长分析（按产品类型、试剂类型、应用、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1898056

血液学市场规模、份额和成长分析（按产品类型、试剂类型、应用、最终用户和地区划分）—产业预测（2026-2033 年）

Hematology Market Size, Share, and Growth Analysis, By Product Type (Hematology Analyzers, Flow Cytometers), By Reagent Type (Coagulation Reagents, Flow Cytometry Reagents), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球血液学市场规模将达到 98.7 亿美元，到 2025 年将达到 106.8 亿美元，到 2033 年将达到 200.6 亿美元，预测期（2026-2033 年）的复合年增长率为 8.2%。

全球血液学市场专注于血液相关疾病的诊断和监测，尤其在贫血、白血病和凝血障碍等疾病中发挥重要作用。人口老化、生活方式改变和环境暴露等因素推动了这些疾病盛行率的上升。诊断技术的创新和新型治疗方法的出现正在拓展血液学的应用范围，进一步推动市场需求。对疾病早期检测和个人化医疗的日益重视，促使人们对能够进行精准血液分析的先进血液分析仪的需求不断增长。然而，先进诊断技术的高成本和严格的监管标准等挑战构成了市场发展的障碍。儘管如此，随着人工智慧 (AI)、就地检验和用户友善仪器等技术的进步，血液学在不同环境下的可及性和有效性不断提高，市场仍然蕴藏着成长机会。

全球血液学市场驱动因素

血液相关疾病（如白血病、淋巴瘤、贫血等）的日益普及是推动血液学诊断需求成长的主要因素。随着这些疾病发生率的上升，医疗专业人员需要先进的血液分析仪来有效评估患者的红血球数量和血红蛋白水平。对早期发现和准确诊断的重视进一步推动了该领域对创新诊断解决方案的需求。随着人们对血液疾病及其对健康影响的认识不断提高，随着医疗系统致力于透过更先进的诊断能力来改善患者预后，血液学市场有望进一步扩张。

限制全球血液学市场的因素

全球血液学市场面临着许多限制因素，其中最主要的是购买和维护先进血液分析仪和流式细胞仪的高成本，尤其是在资源匮乏的医疗机构中。设备升级和人员培训带来的经济负担严重阻碍了这些设备的广泛应用。因此，这些挑战阻碍了市场扩张，限制了关键诊断技术的普及，并最终影响了这些地区血液学服务和创新发展的整体进程。这些经济因素共同构成了致力于改善血液学诊断的相关人员面临的持续挑战。

全球血液学市场趋势

全球血液学市场正呈现出人工智慧 (AI) 在诊断和分析领域日益普及的显着趋势。这项技术进步提高了血液样本评估的准确性和效率，因为 AI 演算法能够处理来自血液分析仪和流式细胞仪的大量数据集。因此，这项创新使医疗专业人员能够更有效地识别血液分析中的细微异常，从而为疾病的准确分类提供更大的帮助。随着 AI 的不断发展，其在血液学领域的应用有望改善临床结果并简化工作流程，最终改变该领域的患者照护和诊断方法。

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较
主要企业简介
- 罗氏（瑞士）
- 默克公司（美国）
- 雅培实验室（美国）
- 武田药品工业株式会社（日本）
- 西门子医疗（德国）
- Alexion Pharmaceuticals（美国）
- Sysmex公司（日本）
- 诺华（瑞士）
- 安进（美国）
- 百时美施贵宝（美国）
- 安捷伦科技（美国）
- Bio-Rad Laboratories（美国）
- 丹纳赫公司（美国）
- 赛默飞世尔科技（美国）
- 迈瑞（中国）
- 贝克曼库尔特（美国）
- 堀场製作所（日本）
- Boule Diagnostics AB（瑞典）
- 罗氏製药股份有限公司（瑞士）

结论与建议

简介目录

Product Code: SQMIG35A2693

Global Hematology Market size was valued at USD 9.87 Billion in 2024 and is poised to grow from USD 10.68 Billion in 2025 to USD 20.06 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).

The global hematology market primarily focuses on diagnosing and monitoring blood-related disorders, critical for conditions like anemia, leukemia, and coagulation issues. The rising prevalence of these disorders is driven by factors such as aging populations, lifestyle changes, and environmental exposures. Innovations in diagnostic technologies and novel therapies are expanding hematology applications, further boosting market demand. The emphasis on early disease detection and personalized medicine is increasing the need for advanced hematology analyzers capable of delivering precise blood analyses. However, challenges like high costs of advanced diagnostics and adherence to stringent regulatory standards pose hurdles. Nevertheless, opportunities for growth remain with technological advancements, including artificial intelligence, point-of-care testing, and user-friendly devices, enhancing access and efficacy in diverse settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hematology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hematology Market Segments Analysis

Global Hematology Market is segmented by Product Type, Reagent Type, Application, End User and region. Based on Product Type, the market is segmented into Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers and Other. Based on Reagent Type, the market is segmented into Coagulation Reagents, Flow Cytometry Reagents, Immuno-Hematology Reagents and Other. Based on Application, the market is segmented into Anemia, Blood Cancer, Hemophilia, Infection and Other. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, Academic and Research Institutes and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hematology Market

The demand for hematology diagnostics is being significantly driven by the rising prevalence of blood-related diseases, including conditions like leukemia, lymphoma, and anemia. As the incidence of these disorders increases, healthcare providers require advanced hematology analyzers to effectively evaluate patients' red blood cell counts and hemoglobin levels. The emphasis on early detection and accurate diagnosis further amplifies the need for innovative diagnostic solutions in this field. With a growing awareness of blood disorders and their impact on health, the hematology market is poised for expansion, as healthcare systems strive to enhance patient outcomes through better diagnostic capabilities.

Restraints in the Global Hematology Market

The global hematology market faces significant constraints due to the high costs associated with acquiring and maintaining advanced hematology analyzers and flow cytometers, particularly in healthcare facilities operating within resource-limited environments. The financial burdens linked to equipment upgrades and the necessary training for personnel create substantial barriers to broader implementation. As a result, these challenges hinder the market's expansion and limit access to essential diagnostic technologies, ultimately affecting the overall advancement of hematology services and innovations in these settings. The combination of these economic factors poses ongoing difficulties for stakeholders aiming to enhance hematological diagnostics.

Market Trends of the Global Hematology Market

The Global Hematology market is witnessing a significant trend towards the integration of Artificial Intelligence (AI) in diagnostics and analysis. This technological advancement enhances the precision and efficiency of blood sample evaluations, as AI algorithms can process extensive datasets from hematology analyzers and flow cytometers. Consequently, this innovation enables healthcare professionals to identify subtle abnormalities in blood profiles more effectively and provides enhanced support for accurate disease classification. As AI continues to evolve, its application in hematology is expected to improve clinical outcomes and streamline workflows, ultimately transforming patient care and diagnostic practices within the field.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global Hematology Market Size by Product Type & CAGR (2026-2033)

Market Overview
Hematology Analyzers
- 3-Part Differential Analyzers
- 5-Part Differential Analyzers
- Point-of-Care Analyzers
Flow Cytometers
Coagulation Analyzers
Slide Stainers
Centrifuges
Hemoglobinometers
Other

Global Hematology Market Size by Reagent Type & CAGR (2026-2033)

Market Overview
Coagulation Reagents
Flow Cytometry Reagents
Immuno-Hematology Reagents
Other

Global Hematology Market Size by Application & CAGR (2026-2033)

Market Overview
Anemia
Blood Cancer
Hemophilia
Infection
Other

Global Hematology Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Other

Global Hematology Market Size & CAGR (2026-2033)

North America (Product Type, Reagent Type, Application, End User)
- US
- Canada
Europe (Product Type, Reagent Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Reagent Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Reagent Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Reagent Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alexion Pharmaceuticals (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boule Diagnostics AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments